Red Queen Bio is using AI to design antibodies for future viruses, WSJ says
OpenAI-backed Red Queen Bio uses AI to design antibodies against bird flu and future viruses, the WSJ reports. It has raised $36M in total.
AI is being used to design antibodies intended to target bird flu and other future viruses.
Evidence
- JournalismTNW2026-09-28
How should this claim be treated?
Truvace Impact Record TRV-2026-1209, v1: “Red Queen Bio is using AI to design antibodies for future viruses, WSJ says.” Truvace, 2026-09-29. /record/TRV-2026-1209 (accessed at citation time). sha256 bd02abfb5c677103…
Calibration history
Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.
Certified into the record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-1209 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.
ace